These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 8905207

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G, Bertolini L, Zoppini G, Zenari L, Falezza G.
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [Abstract] [Full Text] [Related]

  • 23. Von Willebrand factor in diabetic angiopathy.
    Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M.
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [Abstract] [Full Text] [Related]

  • 24. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 25. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A, Ricart J, Todolí J, Micó L, Contreras T, Aznar J.
    Clin Hemorheol Microcirc; 2004 Jun; 30(3-4):411-4. PubMed ID: 15258375
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis].
    Smyr KV, Shcherbak AV, Kozlovskaia LV, Sokolova IA, Bobkova IN, Podorol'skaia LV.
    Ter Arkh; 2010 Jun; 82(1):47-51. PubMed ID: 20364701
    [Abstract] [Full Text] [Related]

  • 33. Hemorheological disturbances in patients with chronic cerebrovascular diseases.
    Szapary L, Horvath B, Marton Z, Alexy T, Demeter N, Szots M, Klabuzai A, Kesmarky G, Juricskay I, Gaal V, Czopf J, Toth K.
    Clin Hemorheol Microcirc; 2004 Jun; 31(1):1-9. PubMed ID: 15272148
    [Abstract] [Full Text] [Related]

  • 34. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases.
    Horvath B, Szapary L, Debreceni L, Feher G, Kenyeres P, Fulop A, Battyani I, Toth K.
    Clin Hemorheol Microcirc; 2009 Jun; 42(1):19-28. PubMed ID: 19363237
    [Abstract] [Full Text] [Related]

  • 35. Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin dependent) diabetes mellitus.
    Osterode W, Holler C, Ulberth F.
    Diabet Med; 1996 Dec; 13(12):1044-50. PubMed ID: 8973886
    [Abstract] [Full Text] [Related]

  • 36. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant.
    Marotta F, Safran P, Tajiri H, Princess G, Anzulovic H, Idéo GM, Rouge A, Seal MG, Idéo G.
    Hepatogastroenterology; 2001 Dec; 48(38):511-7. PubMed ID: 11379344
    [Abstract] [Full Text] [Related]

  • 37. Impact of pancreas and kidney transplantation on determinants of blood and plasma viscosity.
    Mellinghoff AC, Reininger AJ, Wurzinger LJ, Landgraf R, Hepp KD.
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):175-84. PubMed ID: 9699039
    [Abstract] [Full Text] [Related]

  • 38. [Cardiovascular risk factors in diabetic nephropathy].
    Zimmermann J, Schramm L, Mulzer E, Heidbreder E, Henrich HA, Wanner C.
    Med Klin (Munich); 1997 Feb 15; 92(2):74-8. PubMed ID: 9139214
    [Abstract] [Full Text] [Related]

  • 39. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.
    Triolo G, Giardina E, Casiglia D, Scarantino G, Bompiani GD.
    Clin Exp Immunol; 1991 Apr 15; 84(1):53-8. PubMed ID: 2015712
    [Abstract] [Full Text] [Related]

  • 40. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
    Solerte SB, Piovella F, Viola C, Schianca GC, Gamba G, Fioravanti M, Ferrari E.
    Acta Diabetol Lat; 1985 Apr 15; 22(3):239-46. PubMed ID: 3878055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.